TI

Tactics II Investments

North America, Illinois, United States, Northbrook

Description

Tactics II Investments

Investor Profile

Tactics II Investments has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series D (33%)
  • Series B (33%)
  • Series C (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Genetics
  • Life Science
  • Market Research
  • Medical
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tactics II Investments frequently co-invest with?

Baird Capital
North America, Wisconsin, United States, Milwaukee
Co-Investments: 2
Schott
Europe, Rheinland-Pfalz, Germany, Mainz
Co-Investments: 1
Skyline Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
Rose Ventures
North America, North Dakota, United States, Michigan
Co-Investments: 1
Venture Investors
North America, Wisconsin, United States, Madison
Co-Investments: 2
State of Wisconsin Investment Board
North America, Wisconsin, United States, Madison
Co-Investments: 2
Wisconsin Alumni Research Foundation
North America, Wisconsin, United States, Madison
Co-Investments: 2

What are some of recent deals done by Tactics II Investments?

Cellular Dynamics International

Madison, Wisconsin, United States

Cellular Dynamics International develops stem cell technologies for drug development and personalized medicine applications.

BiotechnologyHealth CareMedicalPrecision Medicine
Series CNov 6, 2012
Amount Raised: $21,041,664
Roche NimbleGen

Madison, Wisconsin, United States

Roche NimbleGen provides products and services to the life science research market.

BiotechnologyGeneticsHealth CareLife ScienceMarket Research
Series DApr 17, 2003
Amount Raised: $12,500,000
Roche NimbleGen

Madison, Wisconsin, United States

Roche NimbleGen provides products and services to the life science research market.

BiotechnologyGeneticsHealth CareLife ScienceMarket Research
Series BOct 17, 2001
Amount Raised: $10,500,000